Aclaris Therapeutics (ACRS) Other Working Capital Changes (2014 - 2025)

Aclaris Therapeutics' Other Working Capital Changes history runs 3 years deep, the most recent figure standing at -$854000.0 for Q1 2026.

• On a quarterly basis, Other Working Capital Changes fell 2.52% year-over-year to -$854000.0 in Q1 2026; TTM through Mar 2026 was -$3.8 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$3.8 million, down 115.95% from the prior year.
• Other Working Capital Changes improved to -$854000.0 in Q1 2026 per ACRS's latest filing, from -$1.3 million in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $8.6 million in Q4 2024 and bottomed at -$8.2 million in Q1 2025.
• The 5-year median for Other Working Capital Changes is $271500.0 (2022), against an average of $391666.7.
• Across the five-year window, Other Working Capital Changes dropped 28.04% in 2025 and declined 2.52% in 2026, its largest moves.
• Year by year, Other Working Capital Changes stood at -$1.0 million in 2024, then fell by 28.04% to -$1.3 million in 2025, then jumped by 34.61% to -$854000.0 in 2026.
• Per Business Quant, the three latest ACRS Other Working Capital Changes figures stand at -$854000.0 (Q1 2026), -$1.3 million (Q4 2025), and -$715000.0 (Q3 2025).